Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: The Hong Kong diabetes registry. Diabetes;59:1254-1260

Diabetes

Volumn 59, Issue 9, 2010, Pages

  Bendix, Carstensen ^a,b  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; FOLLOW UP; HONG KONG; HYPERGLYCEMIA; INSULIN TREATMENT; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REGISTER; DIABETES MELLITUS, TYPE 2; HUMAN; INCIDENCE; METHODOLOGY; NEOPLASMS; RISK ASSESSMENT;

COHORT STUDIES; DIABETES MELLITUS, TYPE 2; HONG KONG; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; NEOPLASMS; REGISTRIES; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 77956358166     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0777     Document Type: Letter

References (3)

1. Yang X, Ko GTC, So WY, Ma RCW, Yu LWL, Kong APS, Zhao H, Chow C-C, Tong PCY, Chan JCN. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes 2010;59:1254-1260
2. Johnson JA, Gale EAM. Diabetes, insulin use, and cancer risk: are observational studies part of the solution - or part of the problem? Diabetes 2010;59:1129-1131
3. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003;158:915-920 (Pubitemid 37323253)